MENU

CYCN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cyclerion Therapeutics (CYCN) Ownership - Who owns Cyclerion Therapeutics?

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

245 First Street

Phone

+1 857 327-8778

Employees

1

Web

https://www.cyclerion.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

13.03M

P/E Ratio

N/A

Total Cash

4.57M

Projected Growth

N/A

Total Debt

N/A

Revenue

2.86M

Risk (Beta)

1.17

Dividend Yield

N/A

Total Cash/Share

1.05

Total Debt/Equity

N/A

Revenue/Share

0.55 USD as % of share price

View a ticker or compare two or three

VS

VS

CYCN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CYCN

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology

Profile

Details

Industry

N/A

Address

245 First Street

Phone

+1 857 327-8778

Employees

1

Web

https://www.cyclerion.com